Choose your outcomes: From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey

Fulvio Braido, Ilaria Baiardini, Giorgia Molinengo, Silvia Garuti, Marta Ferrari, Marco Mantero, Francesco Blasi, Giorgio Walter Canonica

Research output: Contribution to journalArticle

Abstract

Background Patient's expectations and needs may influence adherence in chronic obstructive pulmonary disease (COPD). The objectives of this survey were to assess the specific outcomes that patients expected their COPD treatment to improve (patient's personal outcome [PPO]) and to evaluate how the ongoing therapy was able to reach this objective. Methods We performed an exploratory pragmatic survey of COPD patients attending 2 university hospitals for scheduled follow-up visits. Patients had to indicate their PPO, the effect of ongoing treatment on the PPO, the symptom COPD of they expected treatment to improve and how this symptom is currently bothering them. Patients also underwent assessment of lung function and completed the COPD assessment test (CAT). Results We analyzed data from 144 consecutive patients, (62.5% males; age range 54–94; mean age 73.88 ± 8.33). A total of 23 different PPOs were scored, and 44.5% of patients reported an improvement ≥ 6 (mean 4.93 ± 2.27 on a 0–10 points scale) due to ongoing treatment. The correlation between perceived improvement in PPO and CAT score was weak and negative (r = − 0.13, p = 0.11), whereas it was high and significant with FEV1 (r = .35, p = 0.007). The clinical features patients most expected their ongoing treatment to improve were breathlessness (64.6% of patients), cough (13.9%), sputum production (11%) and episodes of exacerbation (8.3%), for which their scores were, respectively, 7.12 ± 1.99, 6.8 ± 2.24, 6.63 ± 2.13, and 8.0 ± 0.94. Conclusion Appropriate assessment of PPO could lead to better long-term management of COPD.

Original languageEnglish
Pages (from-to)85-88
Number of pages4
JournalEuropean Journal of Internal Medicine
Volume34
DOIs
Publication statusPublished - Oct 1 2016

Fingerprint

Chronic Obstructive Pulmonary Disease
Outcome Assessment (Health Care)
Surveys and Questionnaires
Therapeutics
Patient Outcome Assessment
Sputum
Cough
Dyspnea
Lung

Keywords

  • Adherence
  • COPD
  • Personal outcomes

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Choose your outcomes : From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey. / Braido, Fulvio; Baiardini, Ilaria; Molinengo, Giorgia; Garuti, Silvia; Ferrari, Marta; Mantero, Marco; Blasi, Francesco; Canonica, Giorgio Walter.

In: European Journal of Internal Medicine, Vol. 34, 01.10.2016, p. 85-88.

Research output: Contribution to journalArticle

Braido, Fulvio ; Baiardini, Ilaria ; Molinengo, Giorgia ; Garuti, Silvia ; Ferrari, Marta ; Mantero, Marco ; Blasi, Francesco ; Canonica, Giorgio Walter. / Choose your outcomes : From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey. In: European Journal of Internal Medicine. 2016 ; Vol. 34. pp. 85-88.
@article{89af0adf10a94c19afb02d0c4f15fc46,
title = "Choose your outcomes: From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey",
abstract = "Background Patient's expectations and needs may influence adherence in chronic obstructive pulmonary disease (COPD). The objectives of this survey were to assess the specific outcomes that patients expected their COPD treatment to improve (patient's personal outcome [PPO]) and to evaluate how the ongoing therapy was able to reach this objective. Methods We performed an exploratory pragmatic survey of COPD patients attending 2 university hospitals for scheduled follow-up visits. Patients had to indicate their PPO, the effect of ongoing treatment on the PPO, the symptom COPD of they expected treatment to improve and how this symptom is currently bothering them. Patients also underwent assessment of lung function and completed the COPD assessment test (CAT). Results We analyzed data from 144 consecutive patients, (62.5{\%} males; age range 54–94; mean age 73.88 ± 8.33). A total of 23 different PPOs were scored, and 44.5{\%} of patients reported an improvement ≥ 6 (mean 4.93 ± 2.27 on a 0–10 points scale) due to ongoing treatment. The correlation between perceived improvement in PPO and CAT score was weak and negative (r = − 0.13, p = 0.11), whereas it was high and significant with FEV1 (r = .35, p = 0.007). The clinical features patients most expected their ongoing treatment to improve were breathlessness (64.6{\%} of patients), cough (13.9{\%}), sputum production (11{\%}) and episodes of exacerbation (8.3{\%}), for which their scores were, respectively, 7.12 ± 1.99, 6.8 ± 2.24, 6.63 ± 2.13, and 8.0 ± 0.94. Conclusion Appropriate assessment of PPO could lead to better long-term management of COPD.",
keywords = "Adherence, COPD, Personal outcomes",
author = "Fulvio Braido and Ilaria Baiardini and Giorgia Molinengo and Silvia Garuti and Marta Ferrari and Marco Mantero and Francesco Blasi and Canonica, {Giorgio Walter}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.ejim.2016.05.030",
language = "English",
volume = "34",
pages = "85--88",
journal = "European Journal of Internal Medicine",
issn = "0953-6205",
publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Choose your outcomes

T2 - From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey

AU - Braido, Fulvio

AU - Baiardini, Ilaria

AU - Molinengo, Giorgia

AU - Garuti, Silvia

AU - Ferrari, Marta

AU - Mantero, Marco

AU - Blasi, Francesco

AU - Canonica, Giorgio Walter

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background Patient's expectations and needs may influence adherence in chronic obstructive pulmonary disease (COPD). The objectives of this survey were to assess the specific outcomes that patients expected their COPD treatment to improve (patient's personal outcome [PPO]) and to evaluate how the ongoing therapy was able to reach this objective. Methods We performed an exploratory pragmatic survey of COPD patients attending 2 university hospitals for scheduled follow-up visits. Patients had to indicate their PPO, the effect of ongoing treatment on the PPO, the symptom COPD of they expected treatment to improve and how this symptom is currently bothering them. Patients also underwent assessment of lung function and completed the COPD assessment test (CAT). Results We analyzed data from 144 consecutive patients, (62.5% males; age range 54–94; mean age 73.88 ± 8.33). A total of 23 different PPOs were scored, and 44.5% of patients reported an improvement ≥ 6 (mean 4.93 ± 2.27 on a 0–10 points scale) due to ongoing treatment. The correlation between perceived improvement in PPO and CAT score was weak and negative (r = − 0.13, p = 0.11), whereas it was high and significant with FEV1 (r = .35, p = 0.007). The clinical features patients most expected their ongoing treatment to improve were breathlessness (64.6% of patients), cough (13.9%), sputum production (11%) and episodes of exacerbation (8.3%), for which their scores were, respectively, 7.12 ± 1.99, 6.8 ± 2.24, 6.63 ± 2.13, and 8.0 ± 0.94. Conclusion Appropriate assessment of PPO could lead to better long-term management of COPD.

AB - Background Patient's expectations and needs may influence adherence in chronic obstructive pulmonary disease (COPD). The objectives of this survey were to assess the specific outcomes that patients expected their COPD treatment to improve (patient's personal outcome [PPO]) and to evaluate how the ongoing therapy was able to reach this objective. Methods We performed an exploratory pragmatic survey of COPD patients attending 2 university hospitals for scheduled follow-up visits. Patients had to indicate their PPO, the effect of ongoing treatment on the PPO, the symptom COPD of they expected treatment to improve and how this symptom is currently bothering them. Patients also underwent assessment of lung function and completed the COPD assessment test (CAT). Results We analyzed data from 144 consecutive patients, (62.5% males; age range 54–94; mean age 73.88 ± 8.33). A total of 23 different PPOs were scored, and 44.5% of patients reported an improvement ≥ 6 (mean 4.93 ± 2.27 on a 0–10 points scale) due to ongoing treatment. The correlation between perceived improvement in PPO and CAT score was weak and negative (r = − 0.13, p = 0.11), whereas it was high and significant with FEV1 (r = .35, p = 0.007). The clinical features patients most expected their ongoing treatment to improve were breathlessness (64.6% of patients), cough (13.9%), sputum production (11%) and episodes of exacerbation (8.3%), for which their scores were, respectively, 7.12 ± 1.99, 6.8 ± 2.24, 6.63 ± 2.13, and 8.0 ± 0.94. Conclusion Appropriate assessment of PPO could lead to better long-term management of COPD.

KW - Adherence

KW - COPD

KW - Personal outcomes

UR - http://www.scopus.com/inward/record.url?scp=84994158617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994158617&partnerID=8YFLogxK

U2 - 10.1016/j.ejim.2016.05.030

DO - 10.1016/j.ejim.2016.05.030

M3 - Article

AN - SCOPUS:84994158617

VL - 34

SP - 85

EP - 88

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

SN - 0953-6205

ER -